Blood Res.  2023 Sep;58(3):145-148. 10.5045/br.2023.2023069.

Fecal microbiota transplantation for steroid-refractory gastrointestinal graft-versus-host disease

• Kim HM
• Lee J
• Kim S
• Lee JW
• Kim HJ
• Cho YS

• KMID: 2546316
• DOI: http://doi.org/10.5045/br.2023.2023069

Figure

• 

  Fig. 1 Endoscopic response after fecal microbiota transplantation. (A) Patient 1, at time of FMT. (B) Patient 1, on day +108. (C) Patient 2, at time of FMT. (D) Patient 2, on day +35. (E) Patient 3, at time of FMT. (F) Patient 3, on day +201. (G) Patient 4, at time of FMT. (H) Patient 4, on day +45.

Reference

1. Fredricks DN. 2019; The gut microbiota and graft-versus-host disease. J Clin Invest. 129:1808–17. DOI: 10.1172/JCI125797. PMID: 31042160. PMCID: PMC6486325.

2. Martin PJ, Rizzo JD, Wingard JR, et al. 2012; First- and second-line systemic treatment of acute graft-versus-host disease: recommendations of the American Society of Blood and Marrow Transplantation. Biol Blood Marrow Transplant. 18:1150–63. DOI: 10.1016/j.bbmt.2012.04.005. PMID: 22510384. PMCID: PMC3404151.

3. Holler E, Butzhammer P, Schmid K, et al. 2014; Metagenomic analysis of the stool microbiome in patients receiving allogeneic stem cell transplantation: loss of diversity is associated with use of systemic antibiotics and more pronounced in gastrointestinal graft-versus-host disease. Biol Blood Marrow Transplant. 20:640–5. DOI: 10.1016/j.bbmt.2014.01.030. PMID: 24492144. PMCID: PMC4973578.

4. Noor F, Kaysen A, Wilmes P, Schneider JG. 2019; The gut microbiota and hematopoietic stem cell transplantation: challenges and potentials. J Innate Immun. 11:405–15. DOI: 10.1159/000492943. PMID: 30286447. PMCID: PMC6738217.

5. Peled JU, Gomes ALC, Devlin SM, et al. 2020; Microbiota as predictor of mortality in allogeneic hematopoietic-cell transplantation. N Engl J Med. 382:822–34. DOI: 10.1056/NEJMoa1900623. PMID: 32101664. PMCID: PMC7534690.

6. Juul FE, Garborg K, Bretthauer M, et al. 2018; Fecal microbiota transplantation for primary clostridium difficile infection. N Engl J Med. 378:2535–6. DOI: 10.1056/NEJMc1803103. PMID: 29860912.

7. Cui B, Feng Q, Wang H, et al. 2015; Fecal microbiota transplantation through mid-gut for refractory Crohn's disease: safety, feasibility, and efficacy trial results. J Gastroenterol Hepatol. 30:51–8. DOI: 10.1111/jgh.12727. PMID: 25168749.

8. Ianiro G, Eusebi LH, Black CJ, Gasbarrini A, Cammarota G, Ford AC. 2019; Systematic review with meta-analysis: efficacy of faecal microbiota transplantation for the treatment of irritable bowel syndrome. Aliment Pharmacol Ther. 50:240–8. DOI: 10.1111/apt.15330. PMID: 31136009.

9. Qiao X, Biliński J, Wang L, et al. 2023; Safety and efficacy of fecal microbiota transplantation in the treatment of graft-versus-host disease. Bone Marrow Transplant. 58:10–9. DOI: 10.1038/s41409-022-01824-1. PMID: 36167905.

10. Ibrahim RB, Abidi MH, Cronin SM, et al. 2009; Nonabsorbable corticosteroids use in the treatment of gastrointestinal graft-versus-host disease. Biol Blood Marrow Transplant. 15:395–405. DOI: 10.1016/j.bbmt.2008.12.487. PMID: 19285626. PMCID: PMC3809114.

11. Castilla C, Pérez-Simón JA, Sanchez-Guijo FM, et al. 2006; Oral beclomethasone dipropionate for the treatment of gastrointestinal acute graft-versus-host disease (GVHD). Biol Blood Marrow Transplant. 12:936–41. DOI: 10.1016/j.bbmt.2006.05.010. PMID: 16920559.

12. Westin JR, Saliba RM, De Lima M, et al. 2011; Steroid-refractory acute GVHD: predictors and outcomes. Adv Hematol. 2011:601953. DOI: 10.1155/2011/601953. PMID: 22110505. PMCID: PMC3216266. PMID: 10fdb3c57b0c4114b28a6826d6ee477b.

13. Zeiser R, von Bubnoff N, Butler J, et al. 2020; Ruxolitinib for glucocorticoid-refractory acute graft-versus-host disease. N Engl J Med. 382:1800–10. DOI: 10.1056/NEJMoa1917635. PMID: 32320566.

14. Liu Y, Zhao Y, Qi J, et al. 2022; Fecal microbiota transplantation combined with ruxolitinib as a salvage treatment for intestinal steroid-refractory acute GVHD. Exp Hematol Oncol. 11:96. DOI: 10.1186/s40164-022-00350-6. PMID: 36352455. PMCID: PMC9644456. PMID: 48d75dcc279d441a982926ea135603dd.

15. Kusakabe S, Fukushima K, Maeda T, et al. 2020; Pre- and post-serial metagenomic analysis of gut microbiota as a prognostic factor in patients undergoing haematopoietic stem cell transplantation. Br J Haematol. 188:438–49. DOI: 10.1111/bjh.16205. PMID: 31566729.